These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 35063595

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparison Between Pure Component Modeling Approaches for Monitoring Pharmaceutical Powder Blends with Near-Infrared Spectroscopy in Continuous Manufacturing Schemes.
    Rish AJ, Henson SR, Alam MA, Liu Y, Drennen JK, Anderson CA.
    AAPS J; 2022 Jul 12; 24(4):82. PubMed ID: 35821538
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. In-line monitoring of the drug content of powder mixtures and tablets by near-infrared spectroscopy during the continuous direct compression tableting process.
    Järvinen K, Hoehe W, Järvinen M, Poutiainen S, Juuti M, Borchert S.
    Eur J Pharm Sci; 2013 Mar 12; 48(4-5):680-8. PubMed ID: 23313622
    [Abstract] [Full Text] [Related]

  • 25. Near-infrared chemical imaging (NIR-CI) as a process monitoring solution for a production line of roll compaction and tableting.
    Khorasani M, Amigo JM, Sun CC, Bertelsen P, Rantanen J.
    Eur J Pharm Biopharm; 2015 Jun 12; 93():293-302. PubMed ID: 25917640
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Near infrared analysis of pharmaceutical powders with empirical target distribution optimization (ETDO).
    Pedersen T, Rantanen J, Naelapää K, Skibsted E.
    J Pharm Biomed Anal; 2020 Mar 20; 181():113059. PubMed ID: 31978645
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Using scattering and absorption spectra as MCR-hard model constraints for diffuse reflectance measurements of tablets.
    Kessler W, Oelkrug D, Kessler R.
    Anal Chim Acta; 2009 May 29; 642(1-2):127-34. PubMed ID: 19427467
    [Abstract] [Full Text] [Related]

  • 34. Robust calibration design in the pharmaceutical quantitative measurements with near-infrared (NIR) spectroscopy: Avoiding the chemometric pitfalls.
    Xiang D, Berry J, Buntz S, Gargiulo P, Cheney J, Joshi Y, Wabuyele B, Wu H, Hamed M, Hussain AS, Khan MA.
    J Pharm Sci; 2009 Mar 29; 98(3):1155-66. PubMed ID: 18702120
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Prediction of tablet hardness based on near infrared spectra of raw mixed powders by chemometrics.
    Otsuka M, Yamane I.
    J Pharm Sci; 2006 Jul 29; 95(7):1425-33. PubMed ID: 16721793
    [Abstract] [Full Text] [Related]

  • 37. Monitoring of the manufacturing process for ambroxol hydrochloride tablet using NIR-chemometric methods: compression effect on content uniformity model and relevant process parameters testing.
    Yang H, Liao X, Peng F, Wang W, Liu Y, Yan J, Li H.
    Drug Dev Ind Pharm; 2015 Jul 29; 41(11):1877-87. PubMed ID: 25738811
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.